Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Locally Advanced Thyroid Gland Carcinoma × pralsetinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 3 Solid Tumors 1 Lung Neoplasms 1 Locally Advanced Thyroid Gland Carcinoma 1 Gastrointestinal Neoplasms 1 Breast Neoplasms 1

Interventions

vandetanib 1 trametinib 1 pralsetinib 1 lenvatinib 1 larotrectinib 1 entrectinib 1 donafenib 1 dabrafenib 1 cabozantinib 1 apatinib 1 anlotinib 1 Sorafenib 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06482086 2024-12-05

Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer

West China Hospital

Phase 2 Recruiting

Locally Advanced Thyroid Gland Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡